STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

Pharmaceutical companies are exploring strategies to maintain U.S. sales in response to the Trump administration's "most-favored nations" policy, which aims to lower drug prices by preventing companies from charging more for their products abroad.